Guinea hen weed is a tropical plant used in Caribbean, Central American, and South American folk medicine for a wide range of purposes, from fighting infections to managing blood sugar and easing inflammation. Lab studies have identified sulfur-containing compounds in the plant that show genuine biological activity, and a formal clinical trial is now underway to test one of its extracts against cancer. But most of its traditional uses have not yet been confirmed in humans.
The Active Compounds Behind the Claims
Guinea hen weed (known scientifically as Petiveria alliacea, or “anamu” in Latin America) gets its strong garlic-like smell from a family of sulfur compounds. The most studied of these is dibenzyl trisulfide, or DTS. This compound is responsible for many of the plant’s effects in laboratory experiments, including its ability to kill certain bacteria and fungi and to interfere with the growth of cancer cells.
DTS also interacts with several of the liver enzymes your body uses to process medications. That means guinea hen weed could raise or lower the blood levels of drugs you’re already taking, which is a serious concern for anyone on prescription medication.
Antimicrobial Properties
One of the plant’s best-supported traditional uses is fighting infections. Lab testing of both leaf and root extracts has confirmed activity against several common bacteria, including Staphylococcus aureus (the bug behind staph infections), E. coli, and Bacillus subtilis. The root extracts tend to show the strongest antibacterial punch.
On the antifungal side, extracts showed activity against multiple fungal species, including Aspergillus flavus (a mold that can infect the lungs) and several others. Leaf extracts performed slightly better than root extracts against a broader range of fungi. These findings help explain why the plant has been used traditionally for skin infections, but they come from petri dish experiments, not from treating actual infections in people.
Cancer Research
Guinea hen weed has attracted serious scientific interest for its potential anticancer effects. DTS has been shown to inhibit the growth of neuroblastoma cells by disrupting the internal scaffolding those cells need to divide. More recently, a 2022 study found that DTS killed triple-negative breast cancer cells, one of the most aggressive and difficult-to-treat forms of breast cancer. The compound blocked these cells from multiplying and migrating, and it triggered a form of cell death that differs from the usual programmed self-destruct pathway most cancer drugs rely on. Specifically, it caused the membranes of the cells’ waste-processing compartments to break down, destroying them from the inside.
These are lab results, not patient outcomes. However, they were compelling enough to launch the first formal clinical trial of the plant. Registered in October 2022 under identifier NCT05587088, this phase I/II trial is testing a standardized guinea hen weed extract called “Esperanza” in patients with metastatic stomach tumors and acute leukemias. The first phase is determining what dose is safe. The second phase, specifically for stomach tumors, uses a double-blind, placebo-controlled design to look at whether the extract improves patients’ quality of life. This trial represents a major step: it’s the first controlled evaluation of the plant’s anticancer activity in actual patients.
Blood Sugar Lowering
In traditional Cuban and Central American medicine, guinea hen weed is commonly used for diabetes management. Animal research offers some support for this. In one study, extracts from the plant’s leaves and stems lowered blood sugar levels by more than 60% within one hour of oral administration in fasted mice. That’s a dramatic drop, which cuts both ways: it suggests real blood-sugar-lowering potential, but also a risk of dangerously low blood sugar if combined with diabetes medications. No human trials have tested this effect.
Pain and Inflammation
In Guatemalan herbal medicine, guinea hen weed leaf preparations are applied externally to relieve muscle pain. In Cuba, decoctions of the whole plant are used as a general anti-inflammatory. The sulfur compounds in the plant are believed to be responsible, though direct studies measuring the plant’s ability to block specific inflammatory pathways (like the COX enzymes targeted by ibuprofen) are limited. The traditional use is widespread enough that pain relief remains one of the most common reasons people seek out this plant.
How It’s Traditionally Prepared
There is no established clinical dose for guinea hen weed, and preparation methods vary by region. In Guatemala, the leaves are simmered into a tea (decoction) and taken for digestive problems, gas, and fever. In Cuba, the entire plant, roots and all, is boiled and used for cancer, diabetes, and inflammation. Capsules containing dried leaf powder are sold commercially, though their potency and standardization vary widely between products.
Safety Concerns
Guinea hen weed carries real risks that are easy to overlook when the focus is on potential benefits. The most important: it can cause uterine contractions. Methanol extracts of the plant have been documented to stimulate the uterus, and in Cuban folk medicine the plant has historically been used as an abortifacient (a substance to end pregnancy). Pregnant people should avoid it entirely.
The clinical trial of Esperanza extract requires female participants of childbearing age to use non-hormonal contraception from the start of the study through at least six months after their last dose, specifically because the effects on a developing fetus are unknown. This level of caution from researchers tells you something about how seriously they take the reproductive risks.
Because DTS inhibits several liver enzymes involved in drug metabolism, guinea hen weed can alter the effectiveness of a wide range of medications. If you take prescription drugs, particularly for blood sugar, blood clotting, or any condition requiring precise dosing, the interaction potential is significant. The blood-sugar-lowering effect also raises the possibility of hypoglycemia when combined with diabetes medications.